Pediatrix Medical Group (Pediatrix Medical Group) Days Sales Outstanding

: 50.52 (As of Dec. 2023)

View and export this data going back to 1959. Start your Free Trial

Pediatrix Medical Group's average Accounts Receivable for the three months ended in Dec. 2023 was $275 Mil. Pediatrix Medical Group's Revenue for the three months ended in Dec. 2023 was $496 Mil. Hence, Pediatrix Medical Group's Days Sales Outstanding for the three months ended in Dec. 2023 was 50.52.

The historical rank and industry rank for Pediatrix Medical Group's Days Sales Outstanding or its related term are showing as below:

MD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 47.71 Med: 54.64 Max: 107.05
Current: 51.09

During the past 13 years, Pediatrix Medical Group's highest Days Sales Outstanding was 107.05. The lowest was 47.71. And the median was 54.64.

MD's Days Sales Outstanding is ranked worse than
54.56% of 636 companies
in the Healthcare Providers & Services industry
Industry Median: 46.095 vs MD: 51.09

Pediatrix Medical Group's Days Sales Outstanding declined from Dec. 2022 (52.49) to Dec. 2023 (50.52).

Pediatrix Medical Group Days Sales Outstanding Historical Data

The historical data trend for Pediatrix Medical Group's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pediatrix Medical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

96.49

71.17

51.92

55.39

52.07

Pediatrix Medical Group Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding																52.49	53.48	50.09	49.37	50.52

Competitive Comparison

For the Medical Care Facilities subindustry, Pediatrix Medical Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pediatrix Medical Group Days Sales Outstanding Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Pediatrix Medical Group's Days Sales Outstanding falls into.

Pediatrix Medical Group Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Pediatrix Medical Group's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (296.787	+	272.313)	/	2 )	/	1994.64	*	365
=	284.55					/	1994.64	*	365
=	52.07

Pediatrix Medical Group's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (277.352	+	272.313)	/	2 )	/	496.443	*	365 / 4
=	274.8325					/	496.443	*	365 / 4
=	50.52

Pediatrix Medical Group (NYSE:MD) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Pediatrix Medical Group Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Pediatrix Medical Group's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Pediatrix Medical Group (Pediatrix Medical Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pediatrix Medical Group Inc (NYSE:MD) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

MD:Mexico PDC:Germany

Address

1301 Concord Terrace, Sunrise, FL, USA, 33323

Website

https://www.pediatrix.com

Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment, which is physician services. The company generates roughly half of its revenue from the women's and children's services provided, and also roughly half of the company's total revenue is earned in the United States.

Executives

James D Swift	officer: EVP, Chief Operating Officer	1301 CONCORD TERRACE, SUNRISE FL 33323
Moore Mary Ann E	officer: EVP Chief ERM/Legal Ops Off	1301 CONCORD TERRACE, SUNRISE FL 33323
Mark S Ordan	director, officer: Chief Executive Officer	7315 WISCONSIN AVENUE, SUITE #250 WEST, BETHESDA MD 20814
Shirley A Weis	director	11621 RESEARCH CIRCLE, GAINESVILLE FL 32615
Sylvia Jean Young	director	C/O LINCOLN EDUCATIONAL SERVICES CORPORA, 14 SYLVAN WAY, STE. A, PARSIPPANY NJ 07054
Lee Wood	officer: EVP, Natl & Market Operations	1301 CONCORD TERRACE, SUNRISE FL 33323
Curtis Pickert	officer: EVP, Chief Operating Officer	1301 CONCORD TERRACE, SUNRISE FL 33323
Laura A Linynsky	director	1301 CONCORD TERRACE, SUNRISE FL 33323
Roger Md Medel	director, officer: PRES. & CHIEF EXEC. OFFICER	1301 CONCORD TERRACE, SUNRISE FL 33323
John C Pepia	officer: Principal Accounting Officer	1301 CONCORD TERRACE, SUNRISE FL 33323
Roger Mack Hinson	officer: Pres., PDX & OBX Medical Group	C/O MEDNAX, INC., 1301 CONCORD TERRACE, SUNRISE FL 33323
C Marc Richards	officer: EVP, Chief Financial Officer	7315 WISCONSIN AVENUE, SUITE 250-W, BETHESDA MD 20814
Dominic J Andreano	officer: Sr.VP,General Counsel & Secy.	1301 CONCORD TERRACE, SUNRISE FL 33323
Nicholas Nikolopoulos	officer: EVP Chf Strategy & Growth Offi	MEDNAX INC, 1301, SUNRISE FL 33323
Guy P Sansone	director	C/O MEDNAX, 1301 CONCORD TERRACE, SUNRISE FL 33323